Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol-Fentanyl for Colonoscopy Sedation
NCT06148103Completed
- Sponsor
- Zulekha Hospital
- Start
- Dec 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in anxiety disorder and phobic disorder, sponsored by Zulekha Hospital. Primary endpoint: Quality of painless sedation during colonoscopy. Started Dec 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorderphobic disorder
Beyond the preview
Go deeper on NCT06148103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06148103.